Tyche Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is PHENELZINE SULFATE, with a corresponding US DMF Number 31303.
Remarkably, this DMF maintains an Active status since its submission on January 12, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 11, 2017, and payment made on January 09, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II